$OMDA

Duffy Sean P. sold $260K of OMDA

Duffy Sean P. (Chief Executive Officer) sold 14,960 shares of Omada Health, Inc. (OMDA) at $17.36 ($0.26M total) on 2026-06-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Duffy Sean P.
Published Jun 18, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 11:51 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The disclosure adds transparency on insider transactions but does not include new guidance, financial results, or company-specific catalysts.

02

Market read

Traders may treat this as low-signal sentiment data rather than a fundamental catalyst.

03

What to watch

The article provides no context on total compensation, tax obligations, or whether other insiders are selling/buying around the same period.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-18, transaction dated 2026-06-16.

Background

The article is an SEC Form 4 disclosure of an insider sale by Omada Health CEO Sean Duffy.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CEO Sean Duffy sold 14,960 shares in an open-market transaction at $17.3604 on 2026-06-16, per Form 4.

Expected impact

Likely minimal immediate price impact; any effect is more about sentiment than new company information.

Evidence & confidence

The filing is an SEC Form 4 insider transaction and explicitly notes a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

No clear sector read-through; this is company-specific insider activity without operational or regulatory updates.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with valuation or liquidity needs, so traders may still watch for follow-on selling patterns.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Sean P. Duffy

    CEO and director who sold shares under a 10b5-1 plan.

Related articles

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom